Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 1;207(11):1423-1424.
doi: 10.1164/rccm.202303-0373ED.

"Weighting" the Evidence: How Much Bedaquiline Is Enough?

James C M Brust  1
Affiliations
Editorial

"Weighting" the Evidence: How Much Bedaquiline Is Enough?

James C M Brust. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
    Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood SA, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binegdie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Trevisi L, et al. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1525-1532. doi: 10.1164/rccm.202211-2125OC. Am J Respir Crit Care Med. 2023. PMID: 36802336 Free PMC article. Clinical Trial.

References

    1. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med . 2009;360:2397–2405. - PubMed
    1. Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, et al. TMC207-C208 Study Group Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med . 2014;371:723–732. - PubMed
    1. Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, et al. TMC207-C209 Study Group Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J . 2016;47:564–574. - PubMed
    1. Avorn J. Approval of a tuberculosis drug based on a paradoxical surrogate measure. JAMA . 2013;309:1349–1350. - PubMed
    1. Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, et al. Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017 Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med . 2020;8:383–394. - PMC - PubMed

MeSH terms